This content is machine translated Actinic keratosis First S3 guideline provides certainty of action Actinic keratosis is already one of the most frequent clinical pictures in dermatological oncology. However, due to increasing life expectancy, a further increase in the number of affected patients can…
View Post 3 min This content is machine translated Guselkumab High response rate maintained over 4 years Recently presented long-term data from the VOYAGE 1 Phase III clinical trial demonstrate that 84% of patients continued to achieve PASI-90 at 204 weeks.
View Post 4 min This content is machine translated Oral mucosal diseases Interdisciplinary, diverse and complex Lesions of the mucosa may have localized causes, but may also be symptoms of systemic diseases. Thus, changes in the oral mucosa are also features of many skin diseases and…
View Post 3 min This content is machine translated Case Report Arthritis in a teenage football player A teenager presents to the hospital with urticaria, periodic fever, and suspected arthritis as well as myositis and myocarditis. In the search for the appropriate therapy, his condition initially worsens.
View Post 3 min This content is machine translated Risankizumab as a therapeutic option “Real life” interim balance: PASI 100 – realistic target Risankizumab has been approved in Switzerland since April 2019 for moderate to severe plaque psoriasis after unsuccessful therapy with conventional systemic treatment. The high and long-lasting efficacy with rapid response…
View Post 4 min This content is machine translated Atopic dermatitis Topical calcineurin inhibitors: Facts and myths Calcineurin inhibitors can be used in atopic dermatitis as monotherapy or combined with topical corticosteroids. Tacrolimus and pimecrolimus do not cause skin atrophy even with long-term use. Which treatment regimen…
View Post 10 min This content is machine translated Lymphomas The Sézary syndrome The nonspecific symptoms in the early stages lead to a significant diagnostic latency of these primary cutaneous T-cell lymphomas. Extracorporeal photopheresis and new targeted therapies are increasingly improving therapeutic success…
View Post 9 min This content is machine translated Hives Therapy of chronic urticaria In addition to elimination of causes, avoidance of triggers, and induction of tolerance, pharmacologic treatment is the fourth pillar in disease management of this distressing skin disorder. Several 2nd generation…
View Post 6 min This content is machine translated Mucinoses Phenomenology of a clinical picture Mucin deposits are possible in all skin layers, and the site of deposition is not pathognomonic. In addition to primary mucinosis, this deposition dermatosis often manifests as an epiphenomenon. The…
View Post 3 min This content is machine translated Psoriasis Outlook on possible future therapy options As part of this year’s AAD, several speakers reported on on research-stage antipsoriatic agents, which showed promising results in phase 2 trials. Biologics and tyrosine kinase 2 inhibitors are among…
View Post 1 min This content is machine translated Sunscreen for sensitive skin Mineral face sunscreen with “anti-aging” effect Combining infrared A protection and elimination of potentially harmful ingredients, these reformulated SPF50+ products launched three years ago stand out.
